MYC Activation Impairs Cell-Intrinsic IFNγ Signaling and Confers Resistance to Anti-PD1/PD-L1 Therapy in Lung Cancer

Researchers studied the cell-intrinsic response of lung cancer to interferon-γ (IFNγ), a cytokine that promotes immunoresponse and modulates PD-L1 levels.